Across TCGA pan-cancer cohorts, NCOR1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated NCOR1 data layer compared with 26 for mass-spec protein and 8 for mutation status.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher NCOR1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated NCOR1 expression acts as an unfavorable survival marker, although some lineages such as LSCC and PDAC show a favorable association.
LSCC, PDAC, and CCRCC are the cancer types where NCOR1 mass-spec protein most reproducibly stratifies survival.